BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 11894123)

  • 1. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
    Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
    Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
    Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A
    Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between expression of p57(kip2), cyclin E protein, PCNA, and clinicopathological factors in human pancreatic cancer].
    Yue H; Zhang N; Feng XL; Ma SR; Song FL; Yang M; Tang YH
    Ai Zheng; 2003 Jul; 22(7):705-9. PubMed ID: 12866960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma.
    Nan KJ; Guo H; Ruan ZP; Jing Z; Liu SX
    World J Gastroenterol; 2005 Feb; 11(8):1237-40. PubMed ID: 15754413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of p19INK4D expression in hepatocellular carcinoma: relationship to tumor differentiation and patient survival.
    Morishita A; Gong J; Deguchi A; Tani J; Miyoshi H; Yoshida H; Himoto T; Yoneyama H; Mori H; Kato K; Kurokohchi K; Deguchi K; Izuishi K; Suzuki Y; Kushida Y; Haba R; Iwama H; Watanabe S; D'Armiento J; Masaki T
    Oncol Rep; 2011 Dec; 26(6):1363-8. PubMed ID: 21901251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
    Guo RP; Yu WS; Wei W
    Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
    Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
    Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different expression patterns of p27 and p57 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes.
    Curry JL; Richards HW; Huttenbach YT; Medrano EE; Reed JA
    J Cutan Pathol; 2009 Feb; 36(2):197-205. PubMed ID: 18647205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.
    Zhuang PY; Zhang JB; Zhu XD; Zhang W; Wu WZ; Tan YS; Hou J; Tang ZY; Qin LX; Sun HC
    Cancer; 2008 Jun; 112(12):2740-8. PubMed ID: 18412155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma.
    Morishita A; Masaki T; Yoshiji H; Nakai S; Ogi T; Miyauchi Y; Yoshida S; Funaki T; Uchida N; Kita Y; Funakoshi F; Usuki H; Okada S; Izuishi K; Watanabe S; Kurokohchi K; Kuriyama S
    Hepatology; 2004 Sep; 40(3):677-86. PubMed ID: 15349907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
    Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K
    Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
    Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
    Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of P57(kip2) and cyslinE proteins in human pancreatic cancer.
    Yue H; Yu J; Zhao X; Song F; Feng X
    Chin Med J (Engl); 2003 Jun; 116(6):944-6. PubMed ID: 12877813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
    Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
    Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of proliferating cell nucleus antigen and nm23 protein and their relation with metastasis in hepatocellular carcinoma].
    Luo HY; Wang HC; Feng DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):17-9. PubMed ID: 12934386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
    Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
    Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
    Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
    Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma.
    Matsumoto M; Furihata M; Ohtsuki Y; Sasaguri S; Ogoshi S
    Anticancer Res; 2000; 20(3B):1947-52. PubMed ID: 10928132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.